T1	Participants 71 138	patients having coronary stent implantation treated with prasugrel.
T2	Participants 211 295	patients with acute coronary syndromes undergoing percutaneous coronary intervention
T3	Participants 496 618	298 consecutive patients 68 Â± 10 years old (31% >75 years old) underwent stent implantation and received prasugrel therapy
